skip to content
Primary navigation


DrugHetlioz™ [Vanda Pharmaceuticals Inc.]

June 2014

Therapeutic area - Hypnotics

Approval criteria

  • Patient is totally blind with no light perception AND
  • Patient has a diagnosis of non-24 hour sleep/wake disorder AND
  • Patient has tried and failed zolpidem and rozerem AND
  • Hetlioz is being prescribed by a board-certified sleep specialist

Quantity limit

34 capsules per 34-day supply

Background information

Hetlioz is a melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top